Latest Breaking News On - Autosomal recessive non syndromic deafness - Page 1 : comparemela.com

Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting

Regulatory News: Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss.

United statesRafik boudraInstitut pasteurGroup leader technologyPreclinical developmentAmerican society of cellRegulatory newsAnnual american societyGene therapy meetingExhibit hallAutosomal recessive non syndromic deafnessAdeno associated vector based gene therapyCisplatin induced ototoxicityCochlear limitedSudden sensorineural hearing loss

Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 47th Annual Midwinter Meeting

MONTPELLIER, France (BUSINESS WIRE) Jan 29, 2024

United statesMacaca fascicularisPierre louis germainInstitut pasteurHead of preclinical development at sensorionPreclinical developmentHearing instituteAssociation for researchAnnual midwinter meetingAutosomal recessive non syndromic deafnessSaturday februaryPlatinum salonPodium presentationAdeno associated vector based gene therapyNon syndromic deafnessMonday february

Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 47th Annual Midwinter Meeting

Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 47th Annual Midwinter Meeting
oilnow.gy - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oilnow.gy Daily Mail and Mail on Sunday newspapers.

United statesPierre louis germainInstitut pasteurMacaca fascicularisHead of preclinical development at sensorionAssociation for researchHearing institutePreclinical developmentRegulatory newsAnnual midwinter meetingAutosomal recessive non syndromic deafnessSaturday februaryPlatinum salonPodium presentationAdeno associated vector based gene therapyNon syndromic deafness

Sensorion Will Present Two Posters At The American Society Of Cell And Gene Therapy (ASGCT) 26th Annual Meeting

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce its participation in the

United statesLos angelesDavid lawrenceInstitut pasteurMatthew cole jessica hodgsonHead of preclinical developmentVector development platform for inner ear disordersPreclinical developmentCommunications europe franceInternational media relationsStrategic communicationsRegulatory newsChief medical officerAnnual meetingInner earWednesday may

Sensorion Will Present Two Posters at the Association for Research in Otolaryngology ARO 46th Annual MidWinter Meeting

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the

United statesArnaud gieseInstitut pasteurNoemie djokovicSchwierige zeitenMatthew cole jessica hodgsonPreclinical developmentGroup leader animal pharmacology platformVector development platform for inner ear disordersAssociation for researchInternational media relationsConsilium strategic communicationsRegulatory newsAnnual midwinter meetingPreclinical development directorMidwinter meeting